These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1923348)

  • 1. Surfactant and ROP incidence.
    Rankin SJ; Tubman TR; Halliday HL; Johnston SS
    Ophthalmology; 1991 Aug; 98(8):1148-9. PubMed ID: 1923348
    [No Abstract]   [Full Text] [Related]  

  • 2. Calf lung surfactant extract prophylaxis and retinopathy of prematurity.
    Repka MX; Hudak ML; Parsa CF; Tielsch JM
    Ophthalmology; 1992 Apr; 99(4):531-6. PubMed ID: 1584570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinopathy of prematurity in surfactant treated infants.
    Rankin SJ; Tubman TR; Halliday HL; Johnston SS
    Br J Ophthalmol; 1992 Apr; 76(4):202-4. PubMed ID: 1390486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bovine surfactant therapy and retinopathy of prematurity.
    McGinnity FG; Girschek PK; Morin JD; O'Donoghue EP; Dunn MS
    J Pediatr Ophthalmol Strabismus; 1994; 31(4):238-41. PubMed ID: 7807300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surfactant replacement therapy and the prevalence of acute retinopathy of prematurity.
    Tubman TR; Rankin SJ; Halliday HL; Johnston SS
    Biol Neonate; 1992; 61 Suppl 1():54-8. PubMed ID: 1391267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Less severe retinopathy of prematurity induced by surfactant replacement therapy.
    Termote J; Schalij-Delfos NE; Cats BP; Wittebol-Post D; Hoogervorst BR; Brouwers HA
    Acta Paediatr; 1996 Dec; 85(12):1491-6. PubMed ID: 9001664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early regular versus late selective poractant treatment in preterm infants born between 25 and 30 gestational weeks: a prospective randomized multicenter study.
    Dilmen U; Özdemir R; Tatar Aksoy H; Uras N; Demirel N; Kırimi E; Erdeve Ö; Özer E; Baş AY; Gürsoy T; Zenciroğlu A; Ovalı F; Oğuz ŞS
    J Matern Fetal Neonatal Med; 2014 Mar; 27(4):411-5. PubMed ID: 23795582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinopathy of prematurity in very low birth weight infants and the potential protective role of indomethacin.
    Goldman RD; Spierer A; Zhurkovsky A; Kwint J; Schwarcz M; Ben Simon GJ
    Ophthalmic Surg Lasers Imaging; 2010; 41(1):41-7. PubMed ID: 20128569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Screening and risk factors analysis of retinopathy of prematurity].
    Hua SD; Chen YQ; Dong JY; Kong XY; Feng ZC
    Zhonghua Er Ke Za Zhi; 2009 Oct; 47(10):757-61. PubMed ID: 20021810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of the immediate response to surfactant.
    Kuint J; Reichman B; Neumann L; Shinwell ES
    Arch Dis Child Fetal Neonatal Ed; 1994 Nov; 71(3):F170-3. PubMed ID: 7820711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surfactant replacement therapy: a new risk factor in developing retinopathy of prematurity?
    Termote JU; Schalij-Delfos NE; Wittebol-Post D; Brouwers HA; Hoogervorst BR; Cats BP
    Eur J Pediatr; 1994 Feb; 153(2):113-6. PubMed ID: 8157017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surfactant prophylaxis and retinopathy of prematurity.
    Repka MX; Hardy RJ; Phelps DL; Summers CG
    Arch Ophthalmol; 1993 May; 111(5):618-20. PubMed ID: 8489440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: a retrospective study.
    Jeon GW; Oh M; Sin JB
    Yonsei Med J; 2015 Mar; 56(2):433-9. PubMed ID: 25683992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surfactant therapy in newborns with hyaline membrane disease].
    Tsvetkova S; Chernookova V; Efremova R; Nedeva N; Bogdanova V
    Akush Ginekol (Sofiia); 2000; 39 Suppl 2():12-4. PubMed ID: 11188005
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk factors of retinopathy of prematurity in premature infants weighing less than 1600 g.
    Liu PM; Fang PC; Huang CB; Kou HK; Chung MY; Yang YH; Chung CH
    Am J Perinatol; 2005 Feb; 22(2):115-20. PubMed ID: 15731992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of exosurf and survanta surfactants on early clinical course of respiratory distress syndrome and complications of prematurity.
    Modanlou HD; Beharry K; Padilla G; Norris K; Safvati S; Aranda JV
    J Perinatol; 1997; 17(6):455-60. PubMed ID: 9447532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinopathy of prematurity in a controlled trial of prophylactic surfactant treatment.
    Pennefather PM; Tin W; Clarke MP; Fritz S; Strong NP
    Br J Ophthalmol; 1996 May; 80(5):420-4. PubMed ID: 8695563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of retinopathy of prematurity and risk factors among premature infants at a neonatal intensive care unit in Canada.
    Isaza G; Arora S; Bal M; Chaudhary V
    J Pediatr Ophthalmol Strabismus; 2013; 50(1):27-32. PubMed ID: 23205771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter, randomized, double-blind trial of a new porcine surfactant in premature infants with respiratory distress syndrome.
    Rebello CM; Precioso AR; Mascaretti RS;
    Einstein (Sao Paulo); 2014; 12(4):397-404. PubMed ID: 25628188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinopathy of prematurity in extremely premature infants: multiple births versus single births.
    Petriçli İS; Kara C; Demirel N; Ulubaş Işık D; Baş AY
    Turk J Med Sci; 2018 Feb; 48(1):131-135. PubMed ID: 29479971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.